National geographical pattern of COVID-19 hospitalization, case fatalities, and associated factors in patients covered by Iran Health Insurance Organization

Damiri, Soheila; Shojaee, Ali; Dehghani, Mohsen; Shahali, Zahra; Abbasi, Sadrollah; Daroudi, Rajabali

doi:10.1186/s12889-022-13649-0

Cited by 3 publications

(1 citation statement)

References 52 publications

(47 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The IHIO comprises various main funds, such as Civil Servants, Rural, Iranian, Universal Health Insurance, Foreign Citizens, and Other Social Strata funds. The assignment to a particular fund is determined by factors such as occupation, income, and socioeconomic status ( 21 ).…”

Section: Methodsmentioning

confidence: 99%

Drug prescription patterns and their association with mortality and hospitalization duration in COVID-19 patients: insights from big data

Mehrizi,

Golestani,

Malekpour

et al. 2023

Front. Public Health

Self Cite

View full text Add to dashboard Cite

BackgroundDifferent medication prescription patterns have been associated with varying course of disease and outcomes in COVID-19. Health claims data is a rich source of information on disease treatment and outcomes. We aimed to investigate drug prescription patterns and their association with mortality and hospitalization via insurance data for a relatively long period of the pandemic in Iran.MethodsWe retrieved hospitalized patients’ data from Iran Health Insurance Organization (IHIO) spanning 26 months (2020–2022) nationwide. Included were patients with ICD-10 codes U07.1/U07.2 for confirmed/suspected COVID-19. A case was defined as a single hospitalization event for an individual patient. Multiple hospitalizations of a patient within a 30-day interval were aggregated into a single case, while hospitalizations with intervals exceeding 30 days were treated as independent cases. The Anatomical Therapeutic Chemical (ATC) was used for medications classification. The two main study outcomes were general and intensive care unit (ICU) hospitalization periods and mortality. Besides, various demographic and clinical associate factors were analyzed to derive the associations with medication prescription patterns and study outcomes using accelerated failure time (AFT) and logistic regression models.ResultsDuring the 26 months of the study period, 1,113,678 admissions with COVID-19 diagnosis at hospitals working in company with IHIO were recorded. 917,198 cases were detected from the database, among which 51.91% were females and 48.09% were males. Among the main groups of medications, antithrombotics (55.84% [95% CI: 55.74–55.94]), corticosteroids (54.14% [54.04–54.24]), and antibiotics (42.22% [42.12–42.32]) were the top used medications among cases with COVID-19. Investigation of the duration of hospitalization based on main medication groups showed antithrombotics (adjusted median ratio = 0.94 [0.94–0.95]) were significantly associated with shorter periods of overall hospitalization. Also, antithrombotics (adjusted odds ratio = 0.74 [95%CI, 0.73–0.76]), corticosteroids (0.97 [0.95–0.99]), antivirals (0.82 [0.80–0.83]), and ACE inhibitor/ARB (0.79 [0.77–0.80]) were significantly associated with lower mortality.ConclusionOver 2 years of investigation, antithrombotics, corticosteroids, and antibiotics were the top medications for hospitalized patients with COVID-19. Trends in medication prescription varied based on various factors across the country. Medication prescriptions could potentially significantly impact the trends of mortality and hospitalization during epidemics, thereby affecting both health and economic burdens.

show abstract

Section: Methodsmentioning

confidence: 99%

Drug prescription patterns and their association with mortality and hospitalization duration in COVID-19 patients: insights from big data

Mehrizi,

Golestani,

Malekpour

et al. 2023

Front. Public Health

Self Cite

View full text Add to dashboard Cite

show abstract

COVID-19 burden in Iran: disability-adjusted life years analysis from hospital data, 2020–2021

Damiri,

Goharimehr,

Nasehi

et al. 2024

Arch Public Health

View full text Add to dashboard Cite

Patterns of case fatality and hospitalization duration among nearly 1 million hospitalized COVID-19 patients covered by Iran Health Insurance Organization (IHIO) over two years of pandemic: An analysis of associated factors

Mehrizi,

Golestani,

Malekpour

et al. 2024

PLoS ONE

View full text Add to dashboard Cite

Background Different populations and areas of the world experienced diverse COVID-19 hospitalization and mortality rates. Claims data is a systematically recorded source of hospitalized patients’ information that could be used to evaluate the disease management course and outcomes. We aimed to investigate the hospitalization and mortality patterns and associated factors in a huge sample of hospitalized patients. Methods In this retrospective registry-based study, we utilized claim data from the Iran Health Insurance Organization (IHIO) consisting of approximately one million hospitalized patients across various hospitals in Iran over a 26-month period. All records in the hospitalization dataset with ICD-10 codes U07.1/U07.2 for clinically/laboratory confirmed COVID-19 were included. In this study, a case referred to one instance of a patient being hospitalized. If a patient experienced multiple hospitalizations within 30 days, those were aggregated into a single case. However, if hospitalizations had longer intervals, they were considered independent cases. The primary outcomes of study were general and intensive care unit (ICU) hospitalization periods and case fatality rate (CFR) at the hospital. Besides, various demographic and hospitalization-associated factors were analyzed to derive the associations with study outcomes using accelerated failure time (AFT) and logistic regression models. Results A total number of 1 113 678 admissions with COVID-19 diagnosis were recorded by IHIO during the study period, defined as 917 198 cases, including 51.9% females and 48.1% males. The 61–70 age group had the highest number of cases for both sexes. Among defined cases, CFR was 10.36% (95% CI: 10.29–10.42). The >80 age group had the highest CFR (26.01% [95% CI: 25.75–26.27]). The median of overall hospitalization and ICU days were 4 (IQR: 3–7) and 5 (IQR: 2–8), respectively. Male patients had a significantly higher risk for mortality both generally (odds ratio (OR) = 1.36 [1.34–1.37]) and among ICU admitted patients (1.12 [1.09–1.12]). Among various insurance funds, Foreign Citizens had the highest risk of death both generally (adjusted OR = 2.06 [1.91–2.22]) and in ICU (aOR = 1.71 [1.51–1.92]). Increasing age groups was a risk of longer hospitalization, and the >80 age group had the highest risk for overall hospitalization period (median ratio = 1.52 [1.51–1.54]) and at ICU (median ratio = 1.17 [1.16–1.18]). Considering Tehran as the reference province, Sistan and Balcuchestan (aOR = 1.4 [1.32–1.48]), Alborz (aOR = 1.28 [1.22–1.35]), and Khorasan Razavi (aOR = 1.24 [1.20–1.28]) were the provinces with the highest risk of mortality in hospitalized patients. Conclusion Hospitalization data unveiled mortality and duration associations with variables, highlighting provincial outcome disparities in Iran. Using enhanced registry systems in conjunction with other studies, empowers policymakers with evidence for optimizing resource allocation and fortifying healthcare system resilience against future health challenges.

show abstract

National geographical pattern of COVID-19 hospitalization, case fatalities, and associated factors in patients covered by Iran Health Insurance Organization

Cited by 3 publications

References 52 publications

Drug prescription patterns and their association with mortality and hospitalization duration in COVID-19 patients: insights from big data

Drug prescription patterns and their association with mortality and hospitalization duration in COVID-19 patients: insights from big data

COVID-19 burden in Iran: disability-adjusted life years analysis from hospital data, 2020–2021

Patterns of case fatality and hospitalization duration among nearly 1 million hospitalized COVID-19 patients covered by Iran Health Insurance Organization (IHIO) over two years of pandemic: An analysis of associated factors

Contact Info

Product

Resources

About